You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
AbbVie announces quarterly cash dividend
14 February 2025 -

US pharmaceutical company AbbVie Inc (NYSE:ABBV) announced on Thursday a quarterly cash dividend of USD1.64 per share.

This is unchanged from the previous quarterly dividend.

Shareholders of record at 15 April 2025 will receive the dividend on 15 May 2025.

Login
Username:

Password:


Related Headlines

Bavarian Nordic secures USD143.6m US government contract for freeze-dried smallpox/mpox vaccine supply

Lilly declares Q2 2025 dividend

Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics

Emmaus Life Sciences reports drop in revenues, increased loss in 2024

L'Oréal and WHO Foundation partner to expand global skin health access

Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion

ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ

Sirum collaborates with Governor Wes Moore to expand medication access across Maryland

Genomma Lab Internacional announces quarterly dividend

Abbott announces quarterly common dividend

West Pharmaceutical Services announces Q2 dividend

Perrigo increases quarterly dividend

AbbVie announces quarterly cash dividend

hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026

OptiBiotix expands into Indian market with Amazon launch

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025